Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trialsAxel Hauschild, Paul B. Chapman, Ralf Gutzmer et al.|European Journal of Cancer|2020Cited by 69